Biography of Martin Babler
Last update: March 27, 2024Career
Martin was Chairman, President and Chief Executive Officer at Alumis, and Board Member at Prelude Therapeutics. Martin Babler joined Alumis in 2024.
Martin Babler is currently- Chief Executive Officer and Chairman at Alumis - View - Alumis org chart
- Director at 89bio - View - 89bio org chart
- Director at Neoleukin Therapeutics - View - Neoleukin Therapeutics org chart
Create your alert
to follow the career of Martin Babler.
More about Martin Babler
Selected links
Do you need to know more about Martin Babler? More results.
Participate
Social media
- Martin Babler on Google News, Twitter, LinkedIn, YouTube
- View the pictures of Martin Babler
The colleagues of Martin Babler
Company Colleagues
- At Alumis, Martin Babler has 40 colleagues including Sapna Srivastava (Director), Zhengbin Yao (Director)…
- At 89bio, Martin Babler has 21 colleagues including Rohan Palekar (CEO & Director), Morrey Atkinson (Director)…
- At Neoleukin Therapeutics, Martin Babler has 10 colleagues including Sarah Noonberg (Director), Erin Lavelle (Director)…
Homonyms
- Martin Babler - Director - Prelude Therapeutics
Industry Colleagues
- In the Biotechnology industry, Martin Babler has 30,291 colleagues in 2,285 companies located in 40 countries. 14,407 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Martin Babler.
Get in Touch
Use our Premium/VIP Service to contact Martin Babler by email now. Here are a few tips for establishing great contacts.
With Skype,
and ask for Martin Babler.
and ask for Martin Babler.
